Canada Markets closed

Revitalist Lifestyle and Wellness Ltd. (CALM.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
0.0650+0.0100 (+18.18%)
At close: 03:46PM EDT
Full screen
Previous Close0.0550
Open0.0550
Bid0.0550 x N/A
Ask0.0650 x N/A
Day's Range0.0550 - 0.0650
52 Week Range0.0500 - 0.8800
Volume83,464
Avg. Volume145,506
Market Cap3.988M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est0.20
  • Business Wire

    Revitalist Announces Close of Private Placement Totaling $3,944,000

    VANCOUVER, British Columbia, June 15, 2022--REVITALIST LIFESTYLE AND WELLNESS LTD. ("Revitalist" or the "Company") (CSE: CALM) (OTCQB: RVLWF) (FSE: 4DO) is pleased to announce it has closed its second tranche of its private placement offering which was previously announced on April 6, 2022 ("Offering"), bringing the total gross proceeds raised from the Offering to $3,944,000.

  • Business Wire

    Revitalist Reports Q1 2022 Financial Results and Provides Business Update

    VANCOUVER, British Columbia, May 30, 2022--REVITALIST LIFESTYLE AND WELLNESS LTD. ("Revitalist" or the "Company") (CSE: CALM) (OTCQB: RVLWF) (FSE: 4DO), one of the largest publicly listed US based ketamine clinic operations, reported its results for the quarter ended March 31, 2022, and provided a business update. All results are reported under International Financial Reporting Standards ("IFRS") and in Canadian dollars, unless otherwise specified.

  • Business Wire

    Revitalist’s Strategic Initiatives Continue to Exceed Expectations for Execution Giving Company Record High Revenues Since Opening in 2018.

    VANCOUVER, British Columbia, May 12, 2022--REVITALIST LIFESTYLE AND WELLNESS LTD. ("Revitalist" or the "Company") (CSE: CALM) (OTCQB: RVLWF) (FSE: 4DO), one of the largest publicly listed US based ketamine clinic operations, is pleased to report updates on strategic initiatives accomplished in April including becoming a founding partner with the American Association of Psychedelics.